Urs Meyer - Publications

Affiliations: 
D-HEST Eidgenössische Technische Hochschule Zürich, Zürich, ZH, Switzerland 

127 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Raymann S, Schalbetter SM, Schaer R, Bernhardt AC, Mueller FS, Meyer U, Weber-Stadlbauer U. Late prenatal immune activation in mice induces transgenerational effects via the maternal and paternal lineages. Cerebral Cortex (New York, N.Y. : 1991). 33: 2273-2286. PMID 36857721 DOI: 10.1093/cercor/bhac207  0.36
2022 Herrero F, Mueller FS, Gruchot J, Küry P, Weber-Stadlbauer U, Meyer U. Susceptibility and resilience to maternal immune activation are associated with differential expression of endogenous retroviral elements. Brain, Behavior, and Immunity. 107: 201-214. PMID 36243285 DOI: 10.1016/j.bbi.2022.10.006  0.339
2020 Richetto J, Meyer U. Epigenetic Modifications in Schizophrenia and Related Disorders: Molecular Scars of Environmental Exposures and Source of Phenotypic Variability. Biological Psychiatry. PMID 32381277 DOI: 10.1016/J.Biopsych.2020.03.008  0.395
2020 Scarborough J, Mueller F, Arban R, Dorner-Ciossek C, Weber-Stadlbauer U, Rosenbrock H, Meyer U, Richetto J. Preclinical validation of the micropipette-guided drug administration (MDA) method in the maternal immune activation model of neurodevelopmental disorders. Brain, Behavior, and Immunity. PMID 32278850 DOI: 10.1016/J.Bbi.2020.04.015  0.352
2020 Müller F, Scarborough J, Richetto J, Schalbetter S, Weber-Stadlbauer U, Meyer U. M180. SUSCEPTIBILITY AND RESILIENCE IN A MOUSE MODEL OF MATERNAL IMMUNE ACTIVATION Schizophrenia Bulletin. 46: S204-S205. DOI: 10.1093/Schbul/Sbaa030.492  0.445
2020 Schalbetter S, Dawson K, Müller F, Scarborough J, Weber-Stadlbauer U, Ivanov A, Mattei D, Richetto J, Notter T, Meyer U. T179. WHEN TOO LITTLE IS TOO MUCH: TEMPORARY PREFRONTAL MICROGLIA DEFICIENCY DURING ADOLESCENCE IMPAIRS ADULT BRAIN FUNCTIONS Schizophrenia Bulletin. 46: S299-S300. DOI: 10.1093/Schbul/Sbaa029.739  0.396
2020 Scarborough J, Müller F, Dorner-Ciossek C, Arban R, Rosenbrock H, Meyer U, Richetto J. T178. MICROPIPETTE-GUIDED DRUG ADMINISTRATION (MDA) METHOD AS A NOVEL PHARMACOLOGICAL TREATMENT METHOD IN MICE: PRECLINICAL VALIDATION USING RISPERIDONE IN THE MATERNAL IMMUNE ACTIVATION MODEL OF NEURODEVELOPMENTAL DISORDERS Schizophrenia Bulletin. 46: S299-S299. DOI: 10.1093/Schbul/Sbaa029.738  0.351
2020 Müller F, Weber-Stadlbauer U, Meyer U. Susceptibility and Resilience in a Mouse Model of Maternal Immune Activation Biological Psychiatry. 87: S342. DOI: 10.1016/J.Biopsych.2020.02.877  0.387
2020 Weber-Stadlbauer U, Richetto J, Meyer U. Maternal Immune Activation Induces Transgenerational Effects on Prefrontal Cortex Structure and Function Biological Psychiatry. 87: S305. DOI: 10.1016/J.Biopsych.2020.02.786  0.365
2019 Meyer U. Neurodevelopmental Resilience and Susceptibility to Maternal Immune Activation. Trends in Neurosciences. 42: 793-806. PMID 31493924 DOI: 10.1016/J.Tins.2019.08.001  0.39
2019 Purves-Tyson TD, Weber-Stadlbauer U, Richetto J, Rothmond DA, Labouesse MA, Polesel M, Robinson K, Shannon Weickert C, Meyer U. Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation. Molecular Psychiatry. PMID 31168068 DOI: 10.1038/S41380-019-0434-0  0.774
2019 Klarer M, Weber-Stadlbauer U, Arnold M, Langhans W, Meyer U. Abdominal vagal deafferentation alters affective behaviors in rats. Journal of Affective Disorders. 252: 404-412. PMID 31003109 DOI: 10.1016/J.Jad.2019.04.015  0.537
2019 Mueller FS, Richetto J, Hayes LN, Zambon A, Pollak DD, Sawa A, Meyer U, Weber-Stadlbauer U. Influence of poly(I:C) variability on thermoregulation, immune responses and pregnancy outcomes in mouse models of maternal immune activation. Brain, Behavior, and Immunity. PMID 30980948 DOI: 10.1016/J.Bbi.2019.04.019  0.365
2019 Weber-Stadlbauer U, Meyer U. Challenges and opportunities of a-priori and a-posteriori variability in maternal immune activation models Current Opinion in Behavioral Sciences. 28: 119-128. DOI: 10.1016/J.Cobeha.2019.02.006  0.336
2019 Arban R, Richetto J, Scarborough J, Dorner-Ciossek C, Rosenbrock H, Meyer U. S188. The Phosphodiesterase-9 Inhibitor BI 409306 Attenuates Social Interaction and Dopaminergic Deficits in Adult Offspring of poly(I:C)-Based Maternal Immune Activation Neurodevelopmental Mouse Model Biological Psychiatry. 85: S369-S370. DOI: 10.1016/J.Biopsych.2019.03.939  0.37
2019 Schalbetter S, Notter T, Müller F, Scarborough J, Mattei D, Weber U, Richetto J, Meyer U. Abstract # 3224 Role of microglia deficiency in brain maturation and behaviors relevant to neurodevelopmental disorders Brain, Behavior, and Immunity. 81: 5. DOI: 10.1016/J.Bbi.2019.08.024  0.337
2019 Weber-Stadlbauer U, Notter T, Richetto J, Meyer U. Abstract # 3212 Maternal immune activation induces transgenerational effects on prefrontal cortex structure and function Brain, Behavior, and Immunity. 81: 3. DOI: 10.1016/J.Bbi.2019.08.016  0.364
2018 Scarborough J, Mueller F, Weber-Stadlbauer U, Richetto J, Meyer U. Dependency of prepulse inhibition deficits on baseline startle reactivity in a mouse model of the human 22q11.2 microdeletion syndrome. Genes, Brain, and Behavior. e12523. PMID 30267483 DOI: 10.1111/Gbb.12523  0.351
2018 Notter T, Aengenheister L, Weber-Stadlbauer U, Naegeli H, Wick P, Meyer U, Buerki-Thurnherr T. Prenatal exposure to TiO nanoparticles in mice causes behavioral deficits with relevance to autism spectrum disorder and beyond. Translational Psychiatry. 8: 193. PMID 30237468 DOI: 10.1038/S41398-018-0251-2  0.343
2018 Brown AS, Meyer U. Maternal Immune Activation and Neuropsychiatric Illness: A Translational Research Perspective. The American Journal of Psychiatry. appiajp201817121311. PMID 30220221 DOI: 10.1176/Appi.Ajp.2018.17121311  0.402
2018 Giovanoli S, Werge TM, Mortensen PB, Didriksen M, Meyer U. Interactive effects between hemizygous 15q13.3 microdeletion and peripubertal stress on adult behavioral functions. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30188511 DOI: 10.1038/S41386-018-0189-3  0.324
2018 Kentner AC, Bilbo SD, Brown AS, Hsiao EY, McAllister AK, Meyer U, Pearce BD, Pletnikov MV, Snyder SH, Yolken RH, Bauman MD. Maternal immune activation: reporting guidelines to improve the rigor, reproducibility, and transparency of the model. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30188509 DOI: 10.1038/S41386-018-0185-7  0.309
2018 Mueller FS, Polesel M, Richetto J, Meyer U, Weber-Stadlbauer U. Mouse models of maternal immune activation: Mind your caging system! Brain, Behavior, and Immunity. PMID 30026057 DOI: 10.1016/J.Bbi.2018.07.014  0.402
2018 Luan W, Hammond LA, Vuillermot S, Meyer U, Eyles DW. Maternal Vitamin D Prevents Abnormal Dopaminergic Development and Function in a Mouse Model of Prenatal Immune Activation. Scientific Reports. 8: 9741. PMID 29950608 DOI: 10.1038/S41598-018-28090-W  0.423
2018 Fedele S, Arnold M, Krieger JP, Wolfstädter B, Meyer U, Langhans W, Mansouri A. Oleoylethanolamide-induced anorexia in rats is associated with locomotor impairment. Physiological Reports. 6. PMID 29388342 DOI: 10.14814/Phy2.13517  0.545
2018 Klarer M, Krieger JP, Richetto J, Weber-Stadlbauer U, Günther L, Winter C, Arnold M, Langhans W, Meyer U. Abdominal Vagal Afferents Modulate the Brain Transcriptome and Behaviors Relevant to Schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29326171 DOI: 10.1523/Jneurosci.0813-17.2017  0.609
2018 Weber-Stadlbauer U, Richetto J, Labouesse M, Meyer U. 40.2 MATERNAL IMMUNE ACTIVATION LEADS TO INCREASED LEVELS OF INFLAMMATORY CYTOKINES IN THE ABSENCE OF OVERT MICROGLIA ANOMALIES IN THE MIDBRAIN Schizophrenia Bulletin. 44: S65-S65. DOI: 10.1093/Schbul/Sby014.165  0.735
2018 Cabungcal JH, Steullet P, Coyle J, Didriksen M, Gill K, Grace A, Takao H, LaMantia A, Lindemann L, Maynard T, Meyer U, Morishita H, O’Donnell P, Puhl M, Cuenod M, et al. 3.2 PARVALBUMIN INTERNEURON IMPAIRMENT INDUCED BY OXIDATIVE STRESS AS A COMMON PATHOLOGICAL MECHANISM IN ANIMAL MODELS OF SCHIZOPHRENIA Schizophrenia Bulletin. 44: S1-S2. DOI: 10.1093/Schbul/Sby014.004  0.357
2018 Mueller F, Meyer U, Weber-Stadlbauer U. F191. Maternal Immune Activation Models: Mind Your Caging Systems! Biological Psychiatry. 83: S313. DOI: 10.1016/J.Biopsych.2018.02.805  0.334
2018 Weber-Stadlbauer U, Richetto J, Mueller F, Meyer U. 239. Prenatal Immune Activation Modifies Behavioral Phenotypes Across Multiple Generations Biological Psychiatry. 83: S96. DOI: 10.1016/J.Biopsych.2018.02.258  0.377
2017 Notter T, Coughlin JM, Sawa A, Meyer U. Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry. Molecular Psychiatry. 23: 36-47. PMID 29203847 DOI: 10.1038/Mp.2017.232  0.304
2017 Klarer M, Weber-Stadlbauer U, Arnold M, Langhans W, Meyer U. Cognitive Effects of Subdiaphragmatic Vagal Deafferentation in Rats. Neurobiology of Learning and Memory. PMID 28499738 DOI: 10.1016/J.Nlm.2017.05.006  0.513
2017 Notter T, Meyer U. Microglia and schizophrenia: where next? Molecular Psychiatry. PMID 28348384 DOI: 10.1038/Mp.2017.67  0.351
2017 Steullet P, Cabungcal JH, Coyle J, Didriksen M, Gill K, Grace AA, Hensch TK, LaMantia AS, Lindemann L, Maynard TM, Meyer U, Morishita H, O'Donnell P, Puhl M, Cuenod M, et al. Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia. Molecular Psychiatry. PMID 28322275 DOI: 10.1038/Mp.2017.47  0.404
2017 Vuillermot S, Luan W, Meyer U, Eyles D. Vitamin D treatment during pregnancy prevents autism-related phenotypes in a mouse model of maternal immune activation. Molecular Autism. 8: 9. PMID 28316773 DOI: 10.1186/S13229-017-0125-0  0.47
2017 Spencer SJ, Meyer U. Perinatal Programming by Inflammation. Brain, Behavior, and Immunity. PMID 28196717 DOI: 10.1016/J.Bbi.2017.02.007  0.411
2017 Notter T, Coughlin JM, Gschwind T, Weber-Stadlbauer U, Wang Y, Kassiou M, Vernon AC, Benke D, Pomper MG, Sawa A, Meyer U. Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia. Molecular Psychiatry. PMID 28093569 DOI: 10.1038/Mp.2016.248  0.397
2017 Notter T, Coughlin J, Gschwind T, Weber-Stadlbauer U, Wang Y, Kassiou M, Vernon A, Benke D, Pomper M, Sawa A, Meyer U. 117.2 Translational Evaluation of Translocator Protein (TSPO) as a Marker of Neuroinflammation in Schizophrenia Schizophrenia Bulletin. 43: S64-S64. DOI: 10.1093/Schbul/Sbx021.169  0.322
2016 Labouesse MA, Lassalle O, Richetto J, Iafrati J, Weber-Stadlbauer U, Notter T, Gschwind T, Pujadas L, Soriano E, Reichelt AC, Labouesse C, Langhans W, Chavis P, Meyer U. Hypervulnerability of the adolescent prefrontal cortex to nutritional stress via reelin deficiency. Molecular Psychiatry. PMID 27843148 DOI: 10.1038/Mp.2016.193  0.753
2016 Richetto J, Chesters R, Cattaneo A, Labouesse MA, Gutierrez AM, Wood TC, Luoni A, Meyer U, Vernon A, Riva MA. Genome-Wide Transcriptional Profiling and Structural Magnetic Resonance Imaging in the Maternal Immune Activation Model of Neurodevelopmental Disorders. Cerebral Cortex (New York, N.Y. : 1991). PMID 27797829 DOI: 10.1093/Cercor/Bhw320  0.749
2016 Richetto J, Massart R, Weber-Stadlbauer U, Szyf M, Riva MA, Meyer U. Genome-wide DNA Methylation Changes in a Mouse Model of Infection-Mediated Neurodevelopmental Disorders. Biological Psychiatry. PMID 27769567 DOI: 10.1016/J.Biopsych.2016.08.010  0.359
2016 Debost JP, Larsen JT, Munk-Olsen T, Mortensen PB, Meyer U, Petersen L. Joint Effects of Exposure to Prenatal Infection and Peripubertal Psychological Trauma in Schizophrenia. Schizophrenia Bulletin. PMID 27343007 DOI: 10.1093/Schbul/Sbw083  0.403
2016 Markkanen E, Meyer U, Dianov GL. DNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and Beyond. International Journal of Molecular Sciences. 17. PMID 27258260 DOI: 10.3390/Ijms17060856  0.34
2016 Giovanoli S, Engler H, Engler A, Richetto J, Feldon J, Riva MA, Schedlowski M, Meyer U. Preventive effects of minocycline in a neurodevelopmental two-hit model with relevance to schizophrenia. Translational Psychiatry. 6: e772. PMID 27045842 DOI: 10.1038/Tp.2016.38  0.444
2016 Weber-Stadlbauer U, Richetto J, Labouesse MA, Bohacek J, Mansuy IM, Meyer U. Transgenerational transmission and modification of pathological traits induced by prenatal immune activation. Molecular Psychiatry. 22: 102-112. PMID 27021823 DOI: 10.1038/Mp.2016.41  0.775
2016 Nielsen PR, Meyer U, Mortensen PB. Individual and combined effects of maternal anemia and prenatal infection on risk for schizophrenia in offspring. Schizophrenia Research. PMID 26899344 DOI: 10.1016/J.Schres.2016.02.025  0.372
2016 Giovanoli S, Weber-Stadlbauer U, Schedlowski M, Meyer U, Engler H. Prenatal immune activation causes hippocampal synaptic deficits in the absence of overt microglia anomalies. Brain, Behavior, and Immunity. 55: 25-38. PMID 26408796 DOI: 10.1016/J.Bbi.2015.09.015  0.457
2016 Stadlbauer U, Woods SC, Langhans W, Meyer U. Administration of the Y2 receptor agonist PYY3-36 in mice induces multiple behavioral changes relevant to schizophrenia Neuropeptides. 55: 4. DOI: 10.1016/J.Npep.2015.11.007  0.57
2016 Meyer U. Rodent Models of Multiple Environmental Exposures with Relevance to Schizophrenia Handbook of Behavioral Neuroscience. 23: 361-371. DOI: 10.1016/B978-0-12-800981-9.00021-3  0.428
2015 Durieux AM, Fernandes C, Murphy D, Labouesse MA, Giovanoli S, Meyer U, Li Q, So PW, McAlonan G. Targeting Glia with N-Acetylcysteine Modulates Brain Glutamate and Behaviors Relevant to Neurodevelopmental Disorders in C57BL/6J Mice. Frontiers in Behavioral Neuroscience. 9: 343. PMID 26696857 DOI: 10.3389/Fnbeh.2015.00343  0.737
2015 Giovanoli S, Notter T, Richetto J, Labouesse MA, Vuillermot S, Riva MA, Meyer U. Late prenatal immune activation causes hippocampal deficits in the absence of persistent inflammation across aging. Journal of Neuroinflammation. 12: 221. PMID 26602365 DOI: 10.1186/S12974-015-0437-Y  0.764
2015 Labouesse MA, Dong E, Grayson D, Guidotti A, Meyer U. Maternal immune activation induces GAD1 and GAD2 promoter remodeling in the offspring prefrontal cortex. Epigenetics. 0. PMID 26575259 DOI: 10.1080/15592294.2015.1114202  0.751
2015 Labouesse MA, Langhans W, Meyer U. Long-term pathological consequences of prenatal infection: beyond brain disorders. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 309: R1-R12. PMID 25924881 DOI: 10.1152/Ajpregu.00087.2015  0.783
2015 Labouesse MA, Langhans W, Meyer U. Effects of selective estrogen receptor alpha and beta modulators on prepulse inhibition in male mice. Psychopharmacology. 232: 2981-94. PMID 25893642 DOI: 10.1007/S00213-015-3935-9  0.759
2015 Richetto J, Labouesse MA, Poe MM, Cook JM, Grace AA, Riva MA, Meyer U. Behavioral effects of the benzodiazepine-positive allosteric modulator SH-053-2'F-S-CH₃ in an immune-mediated neurodevelopmental disruption model. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25636893 DOI: 10.1093/Ijnp/Pyu055  0.745
2015 Stadlbauer U, Woods SC, Langhans W, Meyer U. PYY3-36: Beyond food intake. Frontiers in Neuroendocrinology. 38: 1-11. PMID 25527432 DOI: 10.1016/J.Yfrne.2014.12.003  0.507
2015 Nielsen PR, Agerbo E, Skogstrand K, Hougaard DM, Meyer U, Mortensen PB. Neonatal levels of inflammatory markers and later risk of schizophrenia. Biological Psychiatry. 77: 548-55. PMID 25152432 DOI: 10.1016/J.Biopsych.2014.07.013  0.39
2015 Labouesse MA, Langhans W, Meyer U. Abnormal context–reward associations in an immune-mediated neurodevelopmental mouse model with relevance to schizophrenia Translational Psychiatry. 5: e637-e637. DOI: 10.1038/Tp.2015.129  0.8
2014 Giovanoli S, Weber L, Meyer U. Single and combined effects of prenatal immune activation and peripubertal stress on parvalbumin and reelin expression in the hippocampal formation. Brain, Behavior, and Immunity. 40: 48-54. PMID 24859043 DOI: 10.1016/J.Bbi.2014.04.005  0.414
2014 Klarer M, Arnold M, Günther L, Winter C, Langhans W, Meyer U. Gut vagal afferents differentially modulate innate anxiety and learned fear. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 7067-76. PMID 24849343 DOI: 10.1523/Jneurosci.0252-14.2014  0.528
2014 Bölte S, Willfors C, Berggren S, Norberg J, Poltrago L, Mevel K, Coco C, Fransson P, Borg J, Sitnikov R, Toro R, Tammimies K, Anderlid BM, Nordgren A, Falk A, ... Meyer U, et al. The Roots of Autism and ADHD Twin Study in Sweden (RATSS). Twin Research and Human Genetics : the Official Journal of the International Society For Twin Studies. 17: 164-76. PMID 24735654 DOI: 10.1017/Thg.2014.12  0.326
2014 Stadlbauer U, Weber E, Langhans W, Meyer U. The Y2 receptor agonist PYY(3-36) increases the behavioural response to novelty and acute dopaminergic drug challenge in mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 407-19. PMID 24131590 DOI: 10.1017/S1461145713001223  0.539
2014 Meyer U. Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems. Biological Psychiatry. 75: 307-15. PMID 23938317 DOI: 10.1016/J.Biopsych.2013.07.011  0.467
2014 Richetto J, Calabrese F, Riva MA, Meyer U. Prenatal immune activation induces maturation-dependent alterations in the prefrontal GABAergic transcriptome. Schizophrenia Bulletin. 40: 351-61. PMID 23328159 DOI: 10.1093/Schbul/Sbs195  0.435
2014 Richetto J, Labouesse MA, Poe MM, Cook JM, Grace AA, Riva MA, Meyer U. Poster #M240 BEHAVIORAL EFFECTS OF THE NOVEL BENZODIAZEPINE POSITIVE ALLOSTERIC MODULATOR SH-053-2′F-S-CH3 IN AN IMMUNE-MEDIATED NEURODEVELOPMENTAL DISRUPTION MODEL Schizophrenia Research. 153: S277. DOI: 10.1016/S0920-9964(14)70790-X  0.721
2014 Labouesse MA, Langhans W, Meyer U. Poster #M12 REWARD DEFICITS IN THE MATERNAL IMMUNE ACTIVATION MODEL Schizophrenia Research. 153: S193. DOI: 10.1016/S0920-9964(14)70562-6  0.768
2014 Labouesse MA, Stadlbauer U, Langhans W, Meyer U. Poster #S19 PERIPUBERTAL HIGH FAT DIET EXPOSURE LEADS TO A DOPAMINE-DEPENDENT DISRUPTION OF SENSORIMOTOR GATING IN ADULTHOOD Schizophrenia Research. 153: S94-S95. DOI: 10.1016/S0920-9964(14)70298-1  0.742
2014 Giovanoli S, Meyer U. Poster #S14 PRENATAL IMMUNE ACTIVATION IMPAIRS SYNAPTIC DEVELOPMENT IN THE ABSENCE OF OVERT GLIAL PATHOLOGY Schizophrenia Research. 153: S93. DOI: 10.1016/S0920-9964(14)70293-2  0.361
2014 Meyer U, Giovanoli S. TRANSIENT NEUROINFLAMMATION IS A KEY MECHANISM MEDIATING THE NEUROPATHOLOGICAL INTERACTIONS BETWEEN PRENATAL IMMUNE CHALLENGE AND PERIPUBERTAL STRESS Schizophrenia Research. 153: S2. DOI: 10.1016/S0920-9964(14)70007-6  0.338
2013 Richetto J, Calabrese F, Meyer U, Riva MA. Prenatal versus postnatal maternal factors in the development of infection-induced working memory impairments in mice. Brain, Behavior, and Immunity. 33: 190-200. PMID 23876745 DOI: 10.1016/J.Bbi.2013.07.006  0.45
2013 Calabrese F, Richetto J, Racagni G, Feldon J, Meyer U, Riva MA. Effects of withdrawal from repeated amphetamine exposure in peri-puberty on neuroplasticity-related genes in mice. Neuroscience. 250: 222-31. PMID 23872394 DOI: 10.1016/J.Neuroscience.2013.07.018  0.41
2013 Labouesse MA, Stadlbauer U, Langhans W, Meyer U. Chronic high fat diet consumption impairs sensorimotor gating in mice. Psychoneuroendocrinology. 38: 2562-74. PMID 23850224 DOI: 10.1016/J.Psyneuen.2013.06.003  0.759
2013 Stadlbauer U, Langhans W, Meyer U. Administration of the Y2 receptor agonist PYY3-36 in mice induces multiple behavioral changes relevant to schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2446-55. PMID 23748226 DOI: 10.1038/Npp.2013.146  0.592
2013 Willi R, Harmeier A, Giovanoli S, Meyer U. Altered GSK3β signaling in an infection-based mouse model of developmental neuropsychiatric disease. Neuropharmacology. 73: 56-65. PMID 23707483 DOI: 10.1016/J.Neuropharm.2013.05.012  0.453
2013 Giovanoli S, Meyer U. Response to comment on "Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice". Science (New York, N.Y.). 340: 811. PMID 23687030 DOI: 10.1126/Science.1238060  0.351
2013 Giovanoli S, Engler H, Engler A, Richetto J, Voget M, Willi R, Winter C, Riva MA, Mortensen PB, Feldon J, Schedlowski M, Meyer U. Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science (New York, N.Y.). 339: 1095-9. PMID 23449593 DOI: 10.1126/Science.1228261  0.437
2013 Anderson G, Berk M, Dodd S, Bechter K, Altamura AC, Dell'osso B, Kanba S, Monji A, Fatemi SH, Buckley P, Debnath M, Das UN, Meyer U, Müller N, Kanchanatawan B, et al. Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 42: 1-4. PMID 23085074 DOI: 10.1016/J.Pnpbp.2012.10.008  0.32
2013 Richetto J, Feldon J, Riva MA, Meyer U. Comparison of the long-term consequences of withdrawal from repeated amphetamine exposure in adolescence and adulthood on information processing and locomotor sensitization in mice. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 160-70. PMID 22609316 DOI: 10.1016/J.Euroneuro.2012.04.005  0.33
2013 Pacheco-López G, Giovanoli S, Langhans W, Meyer U. Priming of metabolic dysfunctions by prenatal immune activation in mice: relevance to schizophrenia. Schizophrenia Bulletin. 39: 319-29. PMID 22186136 DOI: 10.1093/Schbul/Sbr178  0.609
2013 Meyer U. Developmental neuroinflammation and schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 42: 20-34. PMID 22122877 DOI: 10.1016/J.Pnpbp.2011.11.003  0.486
2012 Peleg-Raibstein D, Feldon J, Meyer U. Behavioral animal models of antipsychotic drug actions. Handbook of Experimental Pharmacology. 361-406. PMID 23129339 DOI: 10.1007/978-3-642-25761-2_14  0.422
2012 Eyles D, Feldon J, Meyer U. Schizophrenia: do all roads lead to dopamine or is this where they start? Evidence from two epidemiologically informed developmental rodent models. Translational Psychiatry. 2: e81. PMID 22832818 DOI: 10.1038/Tp.2012.6  0.444
2012 Krstic D, Madhusudan A, Doehner J, Vogel P, Notter T, Imhof C, Manalastas A, Hilfiker M, Pfister S, Schwerdel C, Riether C, Meyer U, Knuesel I. Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice. Journal of Neuroinflammation. 9: 151. PMID 22747753 DOI: 10.1186/1742-2094-9-151  0.315
2012 Vuillermot S, Joodmardi E, Perlmann T, Ögren SO, Feldon J, Meyer U. Prenatal immune activation interacts with genetic Nurr1 deficiency in the development of attentional impairments. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 436-51. PMID 22238080 DOI: 10.1523/Jneurosci.4831-11.2012  0.464
2012 Meyer U, Feldon J. To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology. 62: 1308-21. PMID 21238465 DOI: 10.1016/J.Neuropharm.2011.01.009  0.431
2012 Giovanoli S, Feidon J, Meyer U. Poster #16 SYNERGISTIC INTERACTIONS BETWEEN PRENATAL INFECTION AND PUBERTAL STRESS IN THE DEVELOPMENT OF SCHIZOPHRENIA-RELEVANT ABNORMALITIES Schizophrenia Research. 136: S97. DOI: 10.1016/S0920-9964(12)70332-8  0.361
2012 Eyles DW, Meyer U, Feldon J. 14:30 DOPAMINE AND SCHIZOPHRENIA. DO ALL ROADS LEAD TO DOPAMINIE OR IS IT THE START OF THE JOURNEY? EVIDENCE FROM ANIMAL MODELS Schizophrenia Research. 136: S81-S82. DOI: 10.1016/S0920-9964(12)70293-1  0.378
2012 Meyer U. BRIDGING EPIDEMIOLOGY AND RODENT MODELS: MATERNAL INFLAMMATION AND PSYCHOBIOLOGY OF OFFSPRING Schizophrenia Research. 136: S13. DOI: 10.1016/S0920-9964(12)70043-9  0.316
2011 Vuillermot S, Feldon J, Meyer U. Relationship between sensorimotor gating deficits and dopaminergic neuroanatomy in Nurr1-deficient mice. Experimental Neurology. 232: 22-32. PMID 21820432 DOI: 10.1016/J.Expneurol.2011.07.008  0.387
2011 Vuillermot S, Feldon J, Meyer U. Nurr1 is not essential for the development of prepulse inhibition deficits induced by prenatal immune activation. Brain, Behavior, and Immunity. 25: 1316-21. PMID 21723940 DOI: 10.1016/J.Bbi.2011.06.012  0.5
2011 Meyer U, Schwarz MJ, Müller N. Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond. Pharmacology & Therapeutics. 132: 96-110. PMID 21704074 DOI: 10.1016/J.Pharmthera.2011.06.003  0.349
2011 Meyer U. Anti-inflammatory signaling in schizophrenia. Brain, Behavior, and Immunity. 25: 1507-18. PMID 21664451 DOI: 10.1016/J.Bbi.2011.05.014  0.355
2011 Vuillermot S, Joodmardi E, Perlmann T, Ove Ögren S, Feldon J, Meyer U. Schizophrenia-relevant behaviors in a genetic mouse model of constitutive Nurr1 deficiency. Genes, Brain, and Behavior. 10: 589-603. PMID 21545404 DOI: 10.1111/J.1601-183X.2011.00698.X  0.459
2011 Deng MY, Lam S, Meyer U, Feldon J, Li Q, Wei R, Luk L, Chua SE, Sham P, Wang Y, McAlonan GM. Frontal-subcortical protein expression following prenatal exposure to maternal inflammation. Plos One. 6: e16638. PMID 21347362 DOI: 10.1371/Journal.Pone.0016638  0.33
2011 Meyer U, Feldon J, Dammann O. Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatric Research. 69: 26R-33R. PMID 21289540 DOI: 10.1203/Pdr.0B013E318212C196  0.435
2011 Meyer U, Weiner I, McAlonan GM, Feldon J. The neuropathological contribution of prenatal inflammation to schizophrenia. Expert Review of Neurotherapeutics. 11: 29-32. PMID 21158552 DOI: 10.1586/Ern.10.169  0.427
2011 Feldon J, Giovanoli S, Meyer U. P.3.f.002 Synergistic interactions between prenatal immune challenge and peri-pubertal stress in the disruption of adult behavioural functions European Neuropsychopharmacology. 21: S524. DOI: 10.1016/S0924-977X(11)70852-5  0.305
2011 Pacheco-Lopez G, Langhans W, Meyer U. Prenatal immune priming of metabolic dysfunctions related to schizophrenia Appetite. 57: S33. DOI: 10.1016/J.Appet.2011.05.240  0.59
2010 Bitanihirwe BK, Peleg-Raibstein D, Mouttet F, Feldon J, Meyer U. Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2462-78. PMID 20736993 DOI: 10.1038/Npp.2010.129  0.509
2010 Bitanihirwe BK, Weber L, Feldon J, Meyer U. Cognitive impairment following prenatal immune challenge in mice correlates with prefrontal cortical AKT1 deficiency. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 981-96. PMID 20219156 DOI: 10.1017/S1461145710000192  0.456
2010 Vuillermot S, Weber L, Feldon J, Meyer U. A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 1270-87. PMID 20107055 DOI: 10.1523/Jneurosci.5408-09.2010  0.501
2010 Meyer U, Knuesel I, Nyffeler M, Feldon J. Chronic clozapine treatment improves prenatal infection-induced working memory deficits without influencing adult hippocampal neurogenesis. Psychopharmacology. 208: 531-43. PMID 20041229 DOI: 10.1007/S00213-009-1754-6  0.391
2010 Meyer U, Feldon J. Epidemiology-driven neurodevelopmental animal models of schizophrenia. Progress in Neurobiology. 90: 285-326. PMID 19857543 DOI: 10.1016/J.Pneurobio.2009.10.018  0.467
2010 Meyer U, Spoerri E, Yee BK, Schwarz MJ, Feldon J. Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia. Schizophrenia Bulletin. 36: 607-23. PMID 18845557 DOI: 10.1093/Schbul/Sbn131  0.415
2010 Bitanihirwe BK, Peleg-Raibstein D, Mouttet F, Feldon J, Meyer U. LATE PRENATAL IMMUNE ACTIVATION IN MICE LEADS TO BEHAVIORAL ABNORMALITIES RELEVANT TO THE NEGATIVE SYMPTOMS OF SCHIZOPHRENIA Schizophrenia Research. 117: 273-274. DOI: 10.1016/J.Schres.2010.02.439  0.434
2009 Schwendener S, Meyer U, Feldon J. Deficient maternal care resulting from immunological stress during pregnancy is associated with a sex-dependent enhancement of conditioned fear in the offspring. Journal of Neurodevelopmental Disorders. 1: 15-32. PMID 21547620 DOI: 10.1007/S11689-008-9000-9  0.402
2009 Li Q, Cheung C, Wei R, Hui ES, Feldon J, Meyer U, Chung S, Chua SE, Sham PC, Wu EX, McAlonan GM. Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model. Plos One. 4: e6354. PMID 19629183 DOI: 10.1371/Journal.Pone.0006354  0.5
2009 Meyer U, Feldon J, Fatemi SH. In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neuroscience and Biobehavioral Reviews. 33: 1061-79. PMID 19442688 DOI: 10.1016/J.Neubiorev.2009.05.001  0.455
2009 Meyer U, Feldon J. Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia. Psychopharmacology. 206: 587-602. PMID 19277608 DOI: 10.1007/S00213-009-1504-9  0.475
2009 Meyer U, Feldon J. Neural basis of psychosis-related behaviour in the infection model of schizophrenia. Behavioural Brain Research. 204: 322-34. PMID 19154759 DOI: 10.1016/J.Bbr.2008.12.022  0.492
2009 Winter C, Djodari-Irani A, Sohr R, Morgenstern R, Feldon J, Juckel G, Meyer U. Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 513-24. PMID 18752727 DOI: 10.1017/S1461145708009206  0.493
2009 Meyer U, Feldon J, Yee BK. A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophrenia Bulletin. 35: 959-72. PMID 18408229 DOI: 10.1093/Schbul/Sbn022  0.451
2009 Feldon J, Vuillermot S, Meyer U. P.3.f.003 Prenatal immune activation induces primary defects in dopaminergic development relevant to schizophrenia European Neuropsychopharmacology. 19: S582-S583. DOI: 10.1016/S0924-977X(09)70932-0  0.399
2008 Meyer U, Engler A, Weber L, Schedlowski M, Feldon J. Preliminary evidence for a modulation of fetal dopaminergic development by maternal immune activation during pregnancy. Neuroscience. 154: 701-9. PMID 18495356 DOI: 10.1016/J.Neuroscience.2008.04.031  0.487
2008 Meyer U, Nyffeler M, Yee BK, Knuesel I, Feldon J. Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain, Behavior, and Immunity. 22: 469-86. PMID 18023140 DOI: 10.1016/J.Bbi.2007.09.012  0.515
2008 Meyer U, Murray PJ, Urwyler A, Yee BK, Schedlowski M, Feldon J. Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Molecular Psychiatry. 13: 208-21. PMID 17579604 DOI: 10.1038/Sj.Mp.4002042  0.391
2008 Meyer U, Nyffeler M, Schwendener S, Knuesel I, Yee BK, Feldon J. Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 441-56. PMID 17443130 DOI: 10.1038/Sj.Npp.1301413  0.476
2008 Meyer U. MATERNAL IMMUNE ACTIVATION DURING PREGNANCY MODULATES FETALDOPAMINERGIC DEVELOPMENT: IMPLICATIONS FOR THE ETIOLOGY OF SCHIZOPHRENIA Schizophrenia Research. 102: 202. DOI: 10.1016/S0920-9964(08)70610-8  0.439
2007 Meyer U, Yee BK, Feldon J. The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse? The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 13: 241-56. PMID 17519367 DOI: 10.1177/1073858406296401  0.395
2007 Chang T, Meyer U, Feldon J, Yee BK. Disruption of the US pre-exposure effect and latent inhibition in two-way active avoidance by systemic amphetamine in C57BL/6 mice. Psychopharmacology. 191: 211-21. PMID 17180617 DOI: 10.1007/S00213-006-0649-Z  0.335
2006 Nyffeler M, Meyer U, Yee BK, Feldon J, Knuesel I. Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: implications for schizophrenia. Neuroscience. 143: 51-62. PMID 17045750 DOI: 10.1016/J.Neuroscience.2006.07.029  0.475
2006 Sullivan R, Wilson DA, Feldon J, Yee BK, Meyer U, Richter-Levin G, Avi A, Michael T, Gruss M, Bock J, Helmeke C, Braun K. The International Society for Developmental Psychobiology annual meeting symposium: Impact of early life experiences on brain and behavioral development. Developmental Psychobiology. 48: 583-602. PMID 17016842 DOI: 10.1002/Dev.20170  0.344
2006 Meyer U, Nyffeler M, Engler A, Urwyler A, Schedlowski M, Knuesel I, Yee BK, Feldon J. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 4752-62. PMID 16672647 DOI: 10.1523/Jneurosci.0099-06.2006  0.433
2006 Meyer U, Schwendener S, Feldon J, Yee BK. Prenatal and postnatal maternal contributions in the infection model of schizophrenia. Experimental Brain Research. 173: 243-57. PMID 16552558 DOI: 10.1007/S00221-006-0419-5  0.448
2006 Meyer U, Feldon J, Schedlowski M, Yee BK. Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. Brain, Behavior, and Immunity. 20: 378-88. PMID 16378711 DOI: 10.1016/J.Bbi.2005.11.003  0.432
2005 Meyer U, Feldon J, Schedlowski M, Yee BK. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neuroscience and Biobehavioral Reviews. 29: 913-47. PMID 15964075 DOI: 10.1016/J.Neubiorev.2004.10.012  0.465
2004 Meyer U, Chang DL, Feldon J, Yee BK. Expression of the CS- and US-pre-exposure effects in the conditioned taste aversion paradigm and their abolition following systemic amphetamine treatment in C57BL6/J mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 2140-8. PMID 15238994 DOI: 10.1038/Sj.Npp.1300522  0.301
Show low-probability matches.